Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-15T23:24:38.340Z Has data issue: false hasContentIssue false

Low rates of antibiotic use among ambulatory patients with coronavirus disease 2019 (COVID-19)

Published online by Cambridge University Press:  11 April 2022

Alison G.C. Smith
Affiliation:
Emory University School of Medicine, Atlanta, Georgia
Eli Wilber
Affiliation:
Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia
Paulina A. Rebolledo
Affiliation:
Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GeorgiaHubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia
Joseph Sharp
Affiliation:
Division of General Medicine and Geriatrics, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia
Sheetal Kandiah
Affiliation:
Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia
Daniel S. Graciaa
Affiliation:
Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia
Russell R. Kempker*
Affiliation:
Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia
*
Author for correspondence: Russell Kempker, MD, MSc, 49 Jesse Hill Jr Drive SE, Atlanta, GA 30303. E-mail: rkempke@emory.edu

Abstract

We assessed the prevalence of antibiotic prescriptions among ambulatory patients tested for coronavirus disease 2019 (COVID-19) in a large public US healthcare system and found a low overall rate of antibiotic prescriptions (6.7%). Only 3.8% of positive severe acute respiratory coronavirus virus 2 (SARS-CoV-2) tests were associated with an antibiotic prescription within 7 days.

Information

Type
Concise Communication
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Table 1.Characteristics of Patients Undergoing Outpatient COVID-19 by Receipt of Antibiotics Among All SARS-CoV-2 Testing Encounters

Figure 1

Table 2.Characteristics of Antibiotic Prescriptions for Patients Who Received Antibiotics Within 7 Days of a Positive Outpatient SARS-CoV-2 Test Result

Supplementary material: File

Smith et al. supplementary material

Tables S1-S2

Download Smith et al. supplementary material(File)
File 16.1 KB